At $21,000 a month, it's also costly. Standard Medicare doesn't cover it, and some other insurers are balking, as well. Novocure's vice president for financial and investor relations, Ashley Cordova, said the company has financial assistance programs in an effort to ensure that everyone prescribed the device can get it.